Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study.
about
Mantle cell lymphoma in the era of precision medicine-diagnosis, biomarkers and therapeutic agentsA phase I trial of bortezomib in combination with everolimus for treatment of relapsed/refractory non-Hodgkin lymphoma.Targeting mTOR/p70S6K/glycolysis signaling pathway restores glucocorticoid sensitivity to 4E-BP1 null Burkitt LymphomaEmerging protein kinase inhibitors for the treatment of non-Hodgkin's lymphoma.Current regimens and novel agents for mantle cell lymphoma.Treatment options for mantle cell lymphoma.Novel targeted therapeutics for mantle cell lymphoma--what's on the horizon?The preclinical discovery and development of bortezomib for the treatment of mantle cell lymphoma.Recommendations for Clinical Trial Development in Mantle Cell Lymphoma.A phase 2 study of weekly temsirolimus and bortezomib for relapsed or refractory B-cell non-Hodgkin lymphoma: A Wisconsin Oncology Network study.Pharmacokinetically-targeted dosed everolimus maintenance therapy in lymphoma patients.The molecular pathogenesis of mantle cell lymphoma.
P2860
Q28075606-7473FEF3-DAAB-4D95-8C08-86A6C26B8EBFQ33443555-A607DB23-14FD-455F-9BDB-90D51F2E458DQ35696506-0801311A-62F9-4D7E-8353-E233DA7474D3Q38222824-4B977A29-2469-46A1-A19D-B1BCFAC01D37Q38224186-F800A48A-ED38-4E56-9E26-81227307D32AQ38584922-15EC3618-888D-4100-BAF0-6045BC113587Q38675161-C468ED71-F505-4053-8E05-721D167FC2ABQ39029195-75B14F67-9583-4ADA-AF0F-CDEDF3F11D90Q39045701-7AF644F0-51B0-484D-8751-3781B0511A24Q41665957-D600A0D1-F9C9-4D69-9E57-40FA0D6B7A26Q47320024-A7053C21-3160-4B77-8E8E-DCF09C1C368AQ55007581-8ED33D09-54DF-4E33-ABD0-F00E50CEDE6B
P2860
Everolimus for patients with mantle cell lymphoma refractory to or intolerant of bortezomib: multicentre, single-arm, phase 2 study.
description
2014 nî lūn-bûn
@nan
2014 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մարտին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Everolimus for patients with m ...... re, single-arm, phase 2 study.
@ast
Everolimus for patients with m ...... re, single-arm, phase 2 study.
@en
type
label
Everolimus for patients with m ...... re, single-arm, phase 2 study.
@ast
Everolimus for patients with m ...... re, single-arm, phase 2 study.
@en
prefLabel
Everolimus for patients with m ...... re, single-arm, phase 2 study.
@ast
Everolimus for patients with m ...... re, single-arm, phase 2 study.
@en
P2093
P2860
P356
P1476
Everolimus for patients with m ...... re, single-arm, phase 2 study.
@en
P2093
Anna Robeva
Azzeddine Cherfi
Hakan Kaya
J Thaddeus Beck
John Lister
Joseph M Tuscano
Judith Klimovsky
Leslie L Popplewell
P2860
P304
P356
10.1111/BJH.12780
P407
P577
2014-03-02T00:00:00Z